Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?
2007
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Acute Coronary Care in the Elderly, Part I
2007
Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide
2003
Predicting 30-day major adverse cardiovascular events after primary percutaneous coronary intervention. The RISK-PCI score
2011
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
2008 Standout
Acromegaly
2006 Standout
Echocardiographic evidence for a direct effect of GH/IGF‐I hypersecretion on cardiac mass and function in young acromegalics
1998
Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study
2005
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Acute Coronary Syndrome
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog)
1999
Cardiac Effects of Slow-Release Lanreotide, a Slow-Release Somatostatin Analog, in Acromegalic Patients1
1999
“Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?”
2010
The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department
2010
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores
2009
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: Current status in an era of revascularization and reperfusion
2006
Prognostic Value of the SYNTAX Score in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
2011
Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study
2010
New Antithrombotic Drugs
2012
Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients
2001
Is the Acromegalic Cardiomyopathy Reversible? Effect of 5-Year Normalization of Growth Hormone and Insulin-Like Growth Factor I Levels on Cardiac Performance*
2001
A study to derive a clinical decision rule for triage of emergency department patients with chest pain: design and methodology
2008
Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
2008
Impact of Delay to Angioplasty in Patients With Acute Coronary Syndromes Undergoing Invasive Management
2010
The GRACE score's performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide
2011
Surgical management of coronary artery arising from the wrong coronary sinus, using standard and novel approaches
2007
Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)
2006
The Year in Non-ST-Segment Elevation Acute Coronary Syndromes
2005
CORONARY REVASCULARISATION IN CHRONIC KIDNEY DISEASE PART II: ACUTE CORONARY SYNDROMES
2010
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Prognostic Value of Mid-Regional Pro-Adrenomedullin Levels Taken on Admission and Discharge in Non–ST-Elevation Myocardial Infarction
2010
Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database
2008
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients
2013 StandoutNobel
TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE‐ACS
2005
Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study
2002
Epidemiology of Acromegaly
1999
TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: A meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients
2012
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Acromegaly
1994
Diabetes in Asia
2009 Standout
Usefulness of Changes in Fasting Glucose During Hospitalization to Predict Long-Term Mortality in Patients With Acute Myocardial Infarction
2009
Current Concepts of Integrated Coronary Physiology in the Catheterization Laboratory
2010
Antiplatelet Drugs
2012
Antiplatelet Drugs
2008
Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly
2002
High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study
2015
Sex Versus Gender-Related Characteristics
2016
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery
2006
Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events
2007
Resting Heart Rate in Cardiovascular Disease
2007 Standout
Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome
2006
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
2005
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Effects of Octreofide on left ventricular mass in acromegaly
1994
Sex Differences in Clinical Outcomes After Premature Acute Coronary Syndrome
2016
Usefulness of Coronary Fractional Flow Reserve Measurements in Guiding Clinical Decisions in Intermediate or Equivocal Left Main Coronary Stenoses
2009
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era
2010
Diabetes and Mortality Following Acute Coronary Syndromes
2007
Clopidogrel–Drug Interactions
2011
A Simplified Approach to the Management of Non–ST-Segment Elevation Acute Coronary Syndromes
2005
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
2010
Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era
2006
Risk scores in acute coronary syndrome and percutaneous coronary intervention: A review
2013
Improving long-term risk prediction in patients with acute chest pain: The Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers
2010
Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
2008
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk
2009
Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects
2008
Cardiac Involvement in Acromegaly: Specific Myocardiopathy or Consequence of Systemic Hypertension?1
1997
Adenosine
2014
Prognostic Significance of Admission Heart Failure in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the Canadian Acute Coronary Syndrome Registries)
2006
The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly
2003
Chest pain presenting to the Emergency Department—to stratify risk with GRACE or TIMI?
2007
Growth hormone and the heart
2001
Cardiovascular Effects of a Single Slow Release Lanreotide Injection in Patients with Acromegaly and Left Ventricular Hypertrophy
1999
Expert consensus document on arterial stiffness: methodological issues and clinical applications
2006 Standout
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE
2010
Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events
2005
Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)
2007
Procedural and long-term outcome of primary percutaneous coronary intervention in octogenarians
2010
Enhanced Depression Care for Patients With Acute Coronary Syndrome and Persistent Depressive Symptoms
2010
Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non–ST-segment elevation acute coronary syndromes
2013
Culprit-only or multivessel revascularization in patients with acute coronary syndromes
2007
Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide
1995
Decreased regional blood flow in patients with acromegaly
1998
Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values
2007
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
Reduction of Lung Distensibility in Acromegaly after Suppression of Growth Hormone Hypersecretion
2001
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome
2011
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization
2012
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes
2016
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Acute Myocardial Infarction in Women
2016
Optimal Timing of Intervention in Non–ST-Segment Elevation Acute Coronary Syndromes
2005
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients
2013
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Cardiovascular Effects of Depot Long-Acting Somatostatin Analog Sandostatin LAR in Acromegaly*
2000
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Patient–physician gender concordance and increased mortality among female heart attack patients
2018 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes<subtitle>The Hong Kong Diabetes Registry</subtitle>
2008
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes
2007
Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease
2016
Coronary Artery Anomalies
2007 Standout
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
2008
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
Clinical Features and Outcomes of Women With Unstable Ischemic Heart Disease
2010
Saphenous Vein Graft Stenting and Major Adverse Cardiac Events
2008
Symptomatic anomalous origination of the left coronary artery from the opposite sinus of valsalva. Clinical presentations, diagnosis, and surgical repair.
2006
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Baseline Risk of Major Bleeding in Non–ST-Segment–Elevation Myocardial Infarction
2009
Is 6-month GRACE risk score a useful tool to predict stroke after an acute coronary syndrome?
2014
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Brachial - Ankle Pulse Wave Velocity is a Simple and Independent Predictor of Prognosis in Patients With Acute Coronary Syndrome
2005
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
2010 Standout
High Prevalence of Cardiac Valve Disease in Acromegaly: An Observational, Analytical, Case-Control Study
2003
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis.
2013
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Michael J. Lim being referenced
Physiological Assessment of Coronary Artery Disease in the Cardiac Catheterization Laboratory
2006
Relation of Timing of Cardiac Catheterization to Outcomes in Patients With Non–ST-Segment Elevation Myocardial Infarction or Unstable Angina Pectoris Enrolled in the Multinational Global Registry of Acute Coronary Events
2005
Hemodynamic abnormalities across an anomalous left main coronary artery assessment: Evidence for a dynamic ostial obstruction
2004
Differences in quality of care among patients hospitalized with atrial fibrillation as primary or secondary cause for admission
2005
Lack of relation between imaging and physiology in ostial coronary artery narrowings
2004
Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry
2005
A Validated Prediction Model for All Forms of Acute Coronary Syndrome
2004
Determinants of embolic protection device use: Case study in the acceptance of a new medical technology
2005
Rapid Reduction of Left Ventricular Hypertrophy in Acromegaly after Suppression of Growth Hormone Hypersecretion
1992